| 1918 |
Our company was established in 1918 as Nihon Kankou Co., Ltd. to unify the domestic camphor business. |
| 1918 |
Established Nihon Kankou Co., Ltd. in Kobe City. |
| 1918 |
Our company was established as Nihon Kankou Co., Ltd. to unify the domestic camphor business. |
| 1918-02 |
Established: February 1918 (Taisho 7). |
| 1931 |
Established Nihon Kankou Oil Sales Co., Ltd. (now Nissei Bairis Co., Ltd.). |
| 1933 |
Started manufacturing Japanese Pharmacopoeia camphor (Kankou): acquired factory site in Honjo Village, Muko District, Hyogo Prefecture (Honmatsu Factory, later Kobe Factory). |
| 1941 |
Established Nihon Kankou Chemical Industries Co., Ltd. in Honjo-cho, Higashinada-ku, Kobe City. |
| 1945 |
The headquarters and factory were completely destroyed by the Kobe air raid. |
| 1954 |
Inherited the operations of subsidiary Nihon Kankou Chemical Industries Co., Ltd. and started the fat and oil business (individual fatty acids, etc.). |
| 1958 |
Started manufacturing the lubricant 'Fatty Acid Monoamide (Neutron)' for polyolefin films. |
| 1966 |
Completed the headquarters building in Ubeai-ku (now Chuo-ku), Kobe City. |
| 1970 |
Established the Takasago plant in Takasago City, Hyogo Prefecture. |
| 1971 |
Changed the company name to Nippon Seika Co., Ltd. |
| 1971 |
We changed the company name to Nippon Seika Co., Ltd. and have been striving to develop products and expand business ahead of the needs of the times as a fine chemical manufacturer. |
| 1976 |
Moved the headquarters location to Osaka City. |
| 1977 |
Started manufacturing the toilet fragrance 'Picollet' at the Kobe plant. |
| 1979 |
Listed on the Second Section of the Osaka Stock Exchange. |
| 1981 |
Established a research institute within the Takasago plant. |
| 1989 |
Acquired the Environmental Health Biological Research Center Inc. (now Nissei Bairis Co., Ltd.). |
| 1990 |
Acquired Albous Pharmaceutical Co., Ltd. (now Albous Co., Ltd.). |
| 1991 |
Established the L Plant, a high-purity phospholipid manufacturing plant, at the Takasago plant. |
| 1992 |
Designated to the First Section of the Osaka Stock Exchange. |
| 1995 |
Merged with Yoshikawa Refining Co., Ltd. (now Kakogawa East Plant). |
| 1996 |
Established the FHP precision chemical manufacturing plant at Kakogawa East Plant; established a joint venture Sichuan Nippo Seika Co., Ltd. in China, and began manufacturing and selling fatty acid monoamide; obtained ISO9002 certification for fatty acid monoamide manufacturing at Takasago plant. |
| 1997 |
Started manufacturing cosmetic phospholipids at Kakogawa East Plant and listed on the First Section of the Tokyo Stock Exchange. |
| 1998 |
Obtained ISO9002 certification for cholesterol manufacturing at Kakogawa East Plant. |
| 1999 |
Expanded the L Plant to include a pharmaceutical pre-some manufacturing plant. |
| 2000 |
Obtained ISO14001 certification for Kakogawa East Plant; the pharmaceutical pre-some received GMP compliance approval from FDA and EMEA. |
| 2001 |
Obtained ISO14001 certification for Takasago Plant; started manufacturing functional oil additives at Takasago Plant. |
| 2002 |
Established the New MP clinical trial drug manufacturing plant at Takasago Plant. |
| 2006 |
Established the WJP distillation-only plant at Kakogawa East Plant. |
| 2007 |
Acquired Custom Serve Inc. (now Nissei Plastics Co., Ltd.). |
| 2009 |
Completed the relocation project of Sichuan Nippo Seika Co., Ltd., started operations at the new plant; established a joint venture 'Nirun Seika International Co., Ltd.' in Taiwan. |
| 2010 |
Started manufacturing plastic coating agents at Sichuan Nippo Seika Co., Ltd. |
| 2012 |
Established the FPC pharmaceutical and cosmetic raw material manufacturing plant at Kakogawa East Plant. |
| 2017 |
Established the LP2 pharmaceutical raw material manufacturing plant at Takasago Plant. |
| 2018 |
100th anniversary: 100th anniversary commemorative catalog (PDF: 5.66 MB). |
| 2018-02-12 |
Our company celebrated its 100th anniversary on February 12, 2018. |
| 2018-02-12 |
We celebrated our 100th anniversary. |
| 2018-04 |
In the mid-term management plan (five-year period 2018-2022) that began in April of the same year, under the slogan 'A corporate group that continues to grow toward a new 100 years', we listed on the Tokyo Stock Exchange Prime Market and have been working to strengthen corporate governance. |
| 2018-04 |
We launched the mid-term management plan (five-year period 2018-2022), listed on the Tokyo Stock Exchange Prime Market, and worked to strengthen corporate governance. |
| 2021-10 |
We formulated the long-term vision NFC VISION 2030, titled 'Making everyone smile with the power of Clean', and announced it in October 2021. |
| 2021-10 |
We formulated and announced the long-term vision NFC VISION 2030. |
| 2022 |
Transitioned to the Tokyo Stock Exchange Prime Market; established the NLP dedicated pharmaceutical phospholipid manufacturing plant at Takasago Plant; established the LP3 dedicated plant for Gilead Sciences at Takasago Plant; established the Lipid Office Building at Takasago Plant; Kobe Plant ceased operations. |
| 2023 |
Opened 'Shonan Lab' within Shonan Health Innovation Park; expanded ISO9001 application to all products except those that are GMP or GMP-compliant. |
| 2023-04 |
A new mid-term management plan (four-year period 2023-2026) has started. |
| 2024 |
Opened the Open Lab (The Design & Creation Lab.) on the first floor of the headquarters building. |
| 2025 |
Established the KSC office building at Kakogawa East Plant. |
